Michael Deavers, MD

Professor of Clinical Pathology and Genomic Medicine, Institute for Academic Medicine
Full Clinical Member, Research Institute
Houston Methodist


Dr. Deavers received his MD from the Louisiana State University School of Medicine in New Orleans in 1989. After completing an anatomic and clinical pathology residency at the Walter Reed Army Medical Center in Washington, DC, in 1994, he completed his surgical pathology fellowship at the MD Anderson Cancer Center in Houston, Texas. Dr. Deavers joined the faculty at the MD Anderson Cancer Center as an instructor in the Department of Pathology in 1997. He became Professor of Pathology in 2007. In 2014, Dr. Deavers was recruited to the Department of Pathology and Genomic Medicine at the Houston Methodist Hospital.  Dr. Deavers is the Co-Director of Immunohistochemistry and the Director of the Women’s Health fellowship at the Houston Methodist Hospital.

Prior to joining the Methodist Hospital, Dr. Deavers served first as a Co-Medical Director, and then as the Director of the Immunohistochemistry Laboratory at the MD Anderson Cancer Center from 2005-2014. Additionally, Dr. Deavers was the Director of Clinical Operations in the Department of Pathology and Laboratory Medicine at MD Anderson from 2010-2014. His dedication to the field of pathology research has been recognized by a number of awards, including the Russell L. Holman Memorial Pathology Award and his recognition as one of the Best Doctors in America. Dr. Deavers is board certified in anatomic and clinical pathology. His research interests include gynecologic pathology and immunohistochemistry.

Description of Research

His research interests include gynecologic oncology and sarcoma.

Areas Of Expertise

Gynecologic oncology Immunohistochemistry

Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria
Driver, BR, Portier, BP, Mody, DR, Deavers, M, Bernicker, EH, Kim, MP, Teh, BS, Santacruz, JF, Kopas, L, Munden, RF & Cagle, PT 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 4, pp. 312-317. DOI:

The Utility of Core Needle Biopsy and Fine-Needle Aspiration in the Workup of Tumors of Suspected Müllerian Origin
Crumley, S, Okoye, E, Deavers, M & Coffey, D 2015, Acta Cytologica, vol 59, no. 6, pp. 465-473. DOI:

Hidradenoma papilliferum associated with pregnancy: A case report
McClain, CM, Deavers, MT, Sauls, CD & Diwan, AH 2015, Journal of Cutaneous Pathology, vol 42, no. 12, pp. 983-986. DOI:

Concurrent primary peritoneal low-grade serous carcinoma and endometrial high-grade serous carcinoma
Lockyer, MG, Deavers, MT & Zarrin-Khameh, N 2015, International Journal of Gynecological Pathology, vol 34, no. 3, pp. 288-292. DOI:

Hypertensive Emergency Following Embolization of a Large Adrenal Myelolipoma_Adrenal Medullary Infarction, Pheochromocytoma or Acute Sympathetic Discharge?
Ansari, M, Dela Garza, M, Deavers, M, Balogh, J, Rosenberg, WR, Hai, S, Ruppe, M & Hamilton, DJ 2015, AACE Clinical Case Reports, vol 1, no. 4, pp. e216-e220. DOI:

Collision of ductal carcinoma in situ of anogenital mammary-like glands and vulvar sarcomatoid squamous cell carcinoma
Tran, TAN, Deavers, MT, Carlson, JA & Malpica, A 2015, International Journal of Gynecological Pathology, vol 34, no. 5, pp. 487-494. DOI:

Pulmonary artery intimal sarcoma diagnosed using endobronchial ultrasound-guided transbronchial needle aspiration
Caraway, N, Salina, D, Deavers, M, Morice, R & Landon, G 2015, CytoJournal, vol 12, no. 1, 151667. DOI:

Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants
Li, W, Liang, Y, Deavers, MT, Kamat, AM, Matin, SF, Dinney, CP, Czerniak, B & Guo, CC 2014, American journal of clinical pathology, vol 142, no. 6, pp. 864-871. DOI:

Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to dasatinib
Huang, J, Hu, W, Bottsford-Miller, J, Liu, T, Han, HD, Zand, B, Pradeep, S, Roh, JW, Thanapprapasr, D, Dalton, HJ, Pecot, CV, Rupaimoole, R, Lu, C, Fellman, B, Urbauer, D, Kang, Y, Jennings, NB, Huang, L, Deavers, MT, Broaddus, R, Coleman, RL & Sood, AK 2014, Clinical Cancer Research, vol 20, no. 7, pp. 1846-1855. DOI:

Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi, S, Sun, T, Lin, PP, Deavers, M, Harun, N & Lewis, VO 2014, Clinical Orthopaedics and Related Research, vol 472, no. 3, pp. 983-989. DOI:

ERG and FLI1 protein expression in epithelioid sarcoma
Stockman, DL, Hornick, JL, Deavers, MT, Lev, DC, Lazar, AJ & Wang, WL 2014, Modern Pathology, vol 27, no. 4, pp. 496-501. DOI:

Spontaneous hip dislocation secondary to intraarticular neurofibroma: A case report
Kumar, R, Neto, ADRT, Deavers, MT, Amini, B & Lewis, VO 2014, Skeletal Radiology, vol 43, no. 7, pp. 1007-1011. DOI:

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
Tsang, YT, Deavers, MT, Sun, CC, Kwan, SY, Kuo, E, Malpica, A, Mok, SC, Gershenson, DM & Wong, KK 2013, Journal of Pathology, vol 231, no. 4, pp. 449-456. DOI:

Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix
Tsai, CJ, Sulman, EP, Eifel, PJ, Jhingran, A, Allen, PK, Deavers, MT & Klopp, AH 2013, Gynecologic Oncology, vol 131, no. 3, pp. 645-649. DOI:

Endometrioid stromal sarcoma: A Clinicopathologic study of 63 cases
Masand, RP, Euscher, ED, Deavers, MT & Malpica, A 2013, American Journal of Surgical Pathology, vol 37, no. 11, pp. 1635-1647. DOI:

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value
Lu, KH, Skates, S, Hernandez, MA, Bedi, D, Bevers, T, Leeds, L, Moore, R, Granai, C, Harris, S, Newland, W, Adeyinka, O, Geffen, J, Deavers, MT, Sun, CC, Horick, N, Fritsche, H & Bast, RC 2013, Cancer, vol 119, no. 19, pp. 3454-3461. DOI:

Poor survival with wild-type TP53 ovarian cancer?
Wong, KK, Izaguirre, DI, Kwan, SY, King, ER, Deavers, MT, Sood, AK, Mok, SC & Gershenson, DM 2013, Gynecologic Oncology, vol 130, no. 3, pp. 565-569. DOI:

Erratum: A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (Gynecol Oncol 127 (2012) (538-543))
Coleman, RL, Sill, MW, Lankes, HA, Fader, AN, Finkler, NJ, Hoffman, JS, Rose, PG, Sutton, GP, Drescher, CW, McMeekin, DS, Hu, W, Deavers, M, Godwin, AK, Alpaugh, RK & Sood, AK 2013, Gynecologic Oncology, vol 130, no. 1, pp. 252-253. DOI:

Posttraumatic intramedullary osteochondroma: Report of a case
Kumar, R, Deavers, MT, Dos Reis Teixeira Neto, A, Moon, BS & Madewell, JE 2013, Skeletal Radiology, vol 42, no. 5, pp. 725-728. DOI:

Melan A (A103) is not a marker of mesothelioma
Ordóñez, NG, Shen, SS, Zenali, M & Deavers, MT 2013, Applied Immunohistochemistry and Molecular Morphology, vol 21, no. 2, pp. 181-184. DOI: